SCHEMBL6957812

SCHEMBL6957812

C=C(c1ccccc1)n1c(=O)n(CCCl)c2ccc(Cl)cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HDAC6 Q9UBN7 3/20 0.37
XBP1 P17861 1/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 1/20 0.36
THRB P10828 1/20 0.36
IDO1 P14902 2/20 0.36
TACR1 P25103 2/20 0.35
OPRM1 P35372 2/20 0.35
MAPK8 P45983 1/20 0.35
MAPK9 P45984 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
PRKCA P17252 1/20 0.35
GSK3B P49841 1/20 0.35
HDAC1 Q13547 2/20 0.34
HDAC8 Q9BY41 1/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8565489 0.87 MEN1 (0.44) L3MBTL1PRKCAGSK3BMEN1KMT2A
SCHEMBL6956116 0.82 LMNA (0.54) LMNAL3MBTL1XBP1ALDH1A1HPGD
SCHEMBL6951613 0.73 PGR (0.46) ALDH1A1HPGDSMN1; SMN2KDM4EMEN1
SCHEMBL6644290 0.73 MEN1 (0.41) LMNAALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL7642570 0.72 XBP1 (0.50) LMNAL3MBTL1HDAC6XBP1ALDH1A1
SCHEMBL6948825 0.70 MEN1 (0.46) ALDH1A1SIGMAR1MEN1KMT2A
SCHEMBL1185879 0.70 MEN1 (0.63) L3MBTL1TACR1OPRM1PRKCAGSK3B
SCHEMBL6953268 0.69 LMNA (0.51) LMNAL3MBTL1HDAC6XBP1ALDH1A1
SCHEMBL8119434 0.69 ALDH1A1 (0.46) LMNAALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL8568029 0.69 MEN1 (0.48) LMNAL3MBTL1SMN1; SMN2TACR1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1105388-B1 N-SUBSTITUTED AZABICYCLOHEPTANE DERIVATIVES, PRODUCTION AND USE THEREOF BASF AG (DE) 2003-05-02 EP disclosed
US-6458821-B1 THE NOVEL SUBSTANCES ARE SUITABLE FOR CONTROLLING DISEASES. INTERESTING PROPERTIES AS POTENTIAL NEUROLEPTICS AND ANTIDEPRESSANTS ABBOTT LABORATORIES 2002-10-01 US disclosed